tetano
Editor, Senior Moderator
N Engl J Med
. 2020 Jun 29.
doi: 10.1056/NEJMoa2021756. Online ahead of print.
Multisystem Inflammatory Syndrome in Children in New York State
Elizabeth M Dufort[SUP] 1 [/SUP], Emilia H Koumans[SUP] 1 [/SUP], Eric J Chow[SUP] 1 [/SUP], Elizabeth M Rosenthal[SUP] 1 [/SUP], Alison Muse[SUP] 1 [/SUP], Jemma Rowlands[SUP] 1 [/SUP], Meredith A Barranco[SUP] 1 [/SUP], Angela M Maxted[SUP] 1 [/SUP], Eli S Rosenberg[SUP] 1 [/SUP], Delia Easton[SUP] 1 [/SUP], Tomoko Udo[SUP] 1 [/SUP], Jessica Kumar[SUP] 1 [/SUP], Wendy Pulver[SUP] 1 [/SUP], Lou Smith[SUP] 1 [/SUP], Brad Hutton[SUP] 1 [/SUP], Debra Blog[SUP] 1 [/SUP], Howard Zucker[SUP] 1 [/SUP], New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team
AffiliationsExpand
Abstract
Background: A multisystem inflammatory syndrome in children (MIS-C) is associated with coronavirus disease 2019. The New York State Department of Health (NYSDOH) established active, statewide surveillance to describe hospitalized patients with the syndrome.
Methods: Hospitals in New York State reported cases of Kawasaki's disease, toxic shock syndrome, myocarditis, and potential MIS-C in hospitalized patients younger than 21 years of age and sent medical records to the NYSDOH. We carried out descriptive analyses that summarized the clinical presentation, complications, and outcomes of patients who met the NYSDOH case definition for MIS-C between March 1 and May 10, 2020.
Results: As of May 10, 2020, a total of 191 potential cases were reported to the NYSDOH. Of 95 patients with confirmed MIS-C (laboratory-confirmed acute or recent severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infection) and 4 with suspected MIS-C (met clinical and epidemiologic criteria), 53 (54%) were male; 31 of 78 (40%) were black, and 31 of 85 (36%) were Hispanic. A total of 31 patients (31%) were 0 to 5 years of age, 42 (42%) were 6 to 12 years of age, and 26 (26%) were 13 to 20 years of age. All presented with subjective fever or chills; 97% had tachycardia, 80% had gastrointestinal symptoms, 60% had rash, 56% had conjunctival injection, and 27% had mucosal changes. Elevated levels of C-reactive protein, d-dimer, and troponin were found in 100%, 91%, and 71% of the patients, respectively; 62% received vasopressor support, 53% had evidence of myocarditis, 80% were admitted to an intensive care unit, and 2 died. The median length of hospital stay was 6 days.
Conclusions: The emergence of multisystem inflammatory syndrome in children in New York State coincided with widespread SARS-CoV-2 transmission; this hyperinflammatory syndrome with dermatologic, mucocutaneous, and gastrointestinal manifestations was associated with cardiac dysfunction.
. 2020 Jun 29.
doi: 10.1056/NEJMoa2021756. Online ahead of print.
Multisystem Inflammatory Syndrome in Children in New York State
Elizabeth M Dufort[SUP] 1 [/SUP], Emilia H Koumans[SUP] 1 [/SUP], Eric J Chow[SUP] 1 [/SUP], Elizabeth M Rosenthal[SUP] 1 [/SUP], Alison Muse[SUP] 1 [/SUP], Jemma Rowlands[SUP] 1 [/SUP], Meredith A Barranco[SUP] 1 [/SUP], Angela M Maxted[SUP] 1 [/SUP], Eli S Rosenberg[SUP] 1 [/SUP], Delia Easton[SUP] 1 [/SUP], Tomoko Udo[SUP] 1 [/SUP], Jessica Kumar[SUP] 1 [/SUP], Wendy Pulver[SUP] 1 [/SUP], Lou Smith[SUP] 1 [/SUP], Brad Hutton[SUP] 1 [/SUP], Debra Blog[SUP] 1 [/SUP], Howard Zucker[SUP] 1 [/SUP], New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team
AffiliationsExpand
- PMID: 32598830
- DOI: 10.1056/NEJMoa2021756
Abstract
Background: A multisystem inflammatory syndrome in children (MIS-C) is associated with coronavirus disease 2019. The New York State Department of Health (NYSDOH) established active, statewide surveillance to describe hospitalized patients with the syndrome.
Methods: Hospitals in New York State reported cases of Kawasaki's disease, toxic shock syndrome, myocarditis, and potential MIS-C in hospitalized patients younger than 21 years of age and sent medical records to the NYSDOH. We carried out descriptive analyses that summarized the clinical presentation, complications, and outcomes of patients who met the NYSDOH case definition for MIS-C between March 1 and May 10, 2020.
Results: As of May 10, 2020, a total of 191 potential cases were reported to the NYSDOH. Of 95 patients with confirmed MIS-C (laboratory-confirmed acute or recent severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infection) and 4 with suspected MIS-C (met clinical and epidemiologic criteria), 53 (54%) were male; 31 of 78 (40%) were black, and 31 of 85 (36%) were Hispanic. A total of 31 patients (31%) were 0 to 5 years of age, 42 (42%) were 6 to 12 years of age, and 26 (26%) were 13 to 20 years of age. All presented with subjective fever or chills; 97% had tachycardia, 80% had gastrointestinal symptoms, 60% had rash, 56% had conjunctival injection, and 27% had mucosal changes. Elevated levels of C-reactive protein, d-dimer, and troponin were found in 100%, 91%, and 71% of the patients, respectively; 62% received vasopressor support, 53% had evidence of myocarditis, 80% were admitted to an intensive care unit, and 2 died. The median length of hospital stay was 6 days.
Conclusions: The emergence of multisystem inflammatory syndrome in children in New York State coincided with widespread SARS-CoV-2 transmission; this hyperinflammatory syndrome with dermatologic, mucocutaneous, and gastrointestinal manifestations was associated with cardiac dysfunction.